Tempest Therapeutics, Inc. (TPST) stock
TPSTNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.33−0.01 (-4.24%)
Close on Nov 17, 2026Market cap $4.85MP/E –Yield –
Tempest Therapeutics operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Tempest Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$20.73M. For fiscal 2025 it was -$26.82M. The highest annual figure on record is -$11.16M in fiscal 2012.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$26.82M | – |
| FY2024 | Dec 31, 2024 | -$33.03M | – |
| FY2023 | Dec 31, 2023 | -$27.36M | – |
| FY2022 | Dec 31, 2022 | -$31.07M | – |
| FY2021 | Dec 31, 2021 | -$25.96M | – |
| FY2020 | Dec 31, 2020 | -$19.02M | – |
| FY2019 | Dec 31, 2019 | -$41.22M | – |
| FY2018 | Dec 31, 2018 | -$23.65M | – |
| FY2017 | Dec 31, 2017 | -$20.34M | – |
| FY2016 | Dec 31, 2016 | -$61.73M | – |
| FY2015 | Dec 31, 2015 | -$50.29M | – |
| FY2014 | Dec 31, 2014 | -$30.59M | – |
| FY2013 | Dec 31, 2013 | -$18.09M | – |
| FY2012 | Dec 31, 2012 | -$11.16M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$2.78M | – |
| Q1 FY2026 | Mar 31, 2026 | -$7.60M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.57M | – |
| Q3 FY2025 | Sep 30, 2025 | -$6.78M | – |
| Q2 FY2025 | Jun 30, 2025 | -$8.43M | – |
| Q1 FY2025 | Mar 31, 2025 | -$8.04M | – |
| Q4 FY2024 | Dec 31, 2024 | -$10.15M | – |
| Q3 FY2024 | Sep 30, 2024 | -$10.18M | – |
| Q2 FY2024 | Jun 30, 2024 | -$5.51M | – |
| Q1 FY2024 | Mar 31, 2024 | -$7.19M | – |
| Q4 FY2023 | Dec 31, 2023 | -$6.18M | – |
| Q3 FY2023 | Sep 30, 2023 | -$6.49M | – |
| Q2 FY2023 | Jun 30, 2023 | -$6.39M | – |
| Q1 FY2023 | Mar 31, 2023 | -$8.30M | – |
| Q4 FY2022 | Dec 31, 2022 | -$6.48M | – |
| Q3 FY2022 | Sep 30, 2022 | -$9.07M | – |
| Q2 FY2022 | Jun 30, 2022 | -$8.41M | -6725.2% |
| Q1 FY2022 | Mar 31, 2022 | -$7.11M | – |
| Q4 FY2021 | Dec 31, 2021 | -$7.99M | – |
| Q3 FY2021 | Sep 30, 2021 | -$11.79M | – |
| Q2 FY2021 | Jun 30, 2021 | $127.00K | +217.5% |
| Q1 FY2021 | Mar 31, 2021 | -$6.31M | – |
| Q4 FY2020 | Dec 31, 2020 | -$4.27M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.62M | – |
| Q2 FY2020 | Jun 30, 2020 | $40.00K | – |
| Q1 FY2020 | Mar 31, 2020 | -$10.16M | – |
| Q4 FY2019 | Dec 31, 2019 | -$11.69M | – |
| Q3 FY2019 | Sep 30, 2019 | -$8.36M | – |
| Q2 FY2019 | Jun 30, 2019 | -$10.57M | – |
| Q1 FY2019 | Mar 31, 2019 | -$10.60M | – |
| Q4 FY2018 | Dec 31, 2018 | -$9.23M | -153.5% |
| Q3 FY2018 | Sep 30, 2018 | -$4.72M | – |
| Q2 FY2018 | Jun 30, 2018 | -$4.70M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.00M | – |
| Q4 FY2017 | Dec 31, 2017 | $17.24M | – |
| Q3 FY2017 | Sep 30, 2017 | -$10.30M | – |
| Q2 FY2017 | Jun 30, 2017 | -$12.09M | – |
| Q1 FY2017 | Mar 31, 2017 | -$15.19M | – |
| Q4 FY2016 | Dec 31, 2016 | -$14.97M | – |
| Q3 FY2016 | Sep 30, 2016 | -$15.44M | – |
See a number that looks wrong?